Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- CheckyesterdayChange DetectedAdded a MedlinePlus Genetics topic on Melanoma and updated the page revision from v3.0.1 to v3.0.2. Removed the Back to Top link and the old v3.0.1 reference.SummaryDifference0.3%
- Check8 days agoChange DetectedThe page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the section on Melanoma related topics from MedlinePlus Genetics has been deleted.SummaryDifference0.3%
- Check15 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several related medical topics and resources have been removed, indicating a shift in focus or content strategy.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.